Literature DB >> 10739867

Investigations on human immunodeficiency virus type 1 integrase/DNA binding interactions via molecular dynamics and electrostatics calculations.

R D Lins1, A Adesokan, T A Soares, J M Briggs.   

Abstract

The complete three-dimensional structure of the active site region of the human immunodeficiency virus type 1 (HIV-1) integrase (IN) is not unambiguously known. This region includes a flexible loop comprising residues 141-148 and the N-terminal portion of the helix alpha-4, which contains E152, the third catalytic residue, and Y143, which plays a secondary role in catalysis. Relatively high B-factors exist for most of the residues in the aforementioned region. The HIV-1 IN belongs to the polynucleotidyl transferase superfamily, whose members have been proposed to use two divalent metal ions for catalysis. Although only the position of the first metal ion has been determined crystallographically for the HIV-1 IN, we recently have proposed a binding site for the second metal ion. Based on this information, we have performed two 500-psec molecular dynamics simulations of the catalytic domain of the HIV-1 IN containing two Mg(2)+ ions. In one of the simulations, we included a dianionic phosphate group (HPO(4)(2)-) in the active site to mimic a portion of the DNA backbone of a substrate for the integration reaction. Electrostatics calculations and ionization state predictions were carried out on representative structures taken from the molecular dynamics simulations. Different conformational behaviors of the enzyme were observed, depending upon whether two Mg(2)+ ions were bound or two Mg(2)+ ions plus phosphate. The electrostatic calculations performed on the dynamical structures provide a further refinement about which regions of the catalytic domain of the HIV-1 IN may be involved in the DNA binding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739867     DOI: 10.1016/s0163-7258(99)00059-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  10 in total

1.  HIV-1 integrase catalytic core: molecular dynamics and simulated fluorescence decays.

Authors:  C Laboulais; E Deprez; H Leh; J F Mouscadet; J C Brochon; M Le Bret
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

2.  Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain.

Authors:  Alessandro Brigo; Keun Woo Lee; Gabriela Iurcu Mustata; James M Briggs
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

3.  Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.

Authors:  A L Harper; L M Skinner; M Sudol; M Katzman
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance.

Authors:  Maria L Barreca; Keun Woo Lee; Alba Chimirri; James M Briggs
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

5.  Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA).

Authors:  Devendra K Dhaked; Jitender Verma; Anil Saran; Evans C Coutinho
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

6.  Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection.

Authors:  Tamako Ikeda; Hironori Nishitsuji; Xin Zhou; Nobuo Nara; Takashi Ohashi; Mari Kannagi; Takao Masuda
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Predicting protein-DNA interactions by full search computational docking.

Authors:  Victoria A Roberts; Michael E Pique; Lynn F Ten Eyck; Sheng Li
Journal:  Proteins       Date:  2013-10-18

8.  Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.

Authors:  C Calmels; V Richard de Soultrait; A Caumont; C Desjobert; A Faure; M Fournier; L Tarrago-Litvak; V Parissi
Journal:  Nucleic Acids Res       Date:  2004-03-03       Impact factor: 16.971

9.  Binding modes of diketo-acid inhibitors of HIV-1 integrase: a comparative molecular dynamics simulation study.

Authors:  Meilan Huang; Guy H Grant; W Graham Richards
Journal:  J Mol Graph Model       Date:  2011-04-09       Impact factor: 2.518

Review 10.  Raltegravir: molecular basis of its mechanism of action.

Authors:  Jean-Francois Mouscadet; Luba Tchertanov
Journal:  Eur J Med Res       Date:  2009-11-24       Impact factor: 2.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.